We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00886691
Recruitment Status : Unknown
Verified May 2013 by Gynecologic Oncology Group.
Recruitment status was:  Active, not recruiting
First Posted : April 23, 2009
Last Update Posted : May 30, 2013
National Cancer Institute (NCI)
Genentech, Inc.
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Gynecologic Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2014
  Study Completion Date : No date given